Solid Organ Transplant

H9454: Autologous EBV Specific CTLs for Prophylaxis and Therapy of EBV Lymphoma Post Solid Organ Transplant: The study uses Autologous EBV specific T-Lymphocytes to prevent or treat EBV related lymphoproliferative disorder following a solid organ transplant.

 

 

 

CAGT Home | BCM Home | Privacy Notices

©2002, Cell And Gene Therapy, Baylor College of Medicine
One Baylor Plaza, N1002, Houston, TX 77030, (713)798-1246
URL: http://www.bcm.edu/genetherapy Email:cagt@bcm.edu
(Modified: September 21st, 2007 - jb)